DT Cloud Acquisition Corporation
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Feb 21, 2024 |
| CEO | Shaoke Li |
| Left Lead | Brookline Capital Markets |
| IPO Cash in Trust | 100.5% |
| SPAC Tenor | 9 + 3 + (12*1) |
| IPO Sector |
General
Not specified |
| IPO Geography | Global |
| Target Company | Maius |
| Deal Announced | Oct 23, 2024 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
| Price | $10.38 |
|---|---|
| Last closing price | $10.38 |
| H/L, today | $10.38 / $10.39 |
| Volume, today | 4 |
| Volume, 3-month avg. | N/A |
No credit card required
Sign in for more on DT Cloud Acquisition Corporation:
- Structure and cap table
- 6 directors & officers
- 11 filings and events
- 1 underwriters
- 7 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Shaoke Li | 39 | Chairperson and CEO |
| Thomas Trent Stout | 45 | CFO and Director |
| Michael David Osowski | 52 | Director |
| Guojian Chen | 31 | Director |
| Olivia Wenxi He | 44 | Director |
| Hao (Kevin) Chen | 41 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
| Brookline Capital Markets | BR | 6,000,000 | units |
| 6,000,000 | units | ||
| Up-Front UW fee | 1.40 | % | |
| Deferred UW fee |
2.50 | % |
Sign in to view more advisor data.
Filings
| Aug 31, 2022 | Initial S-1 |
| Oct 6, 2022 |
Amended S-1
Sign In to view filing content. |
| Nov 9, 2022 |
Amended S-1
Sign In to view filing content. |
| Dec 19, 2023 |
Amended S-1
Sign In to view filing content. |
| Jan 23, 2024 |
Amended S-1
Sign In to view filing content. |
| Feb 20, 2024 |
PR announcing pricing of $60mm IPO
Sign In to view filing content. |
| Feb 21, 2024 | 424B4 IPO Prospectus |
| Feb 23, 2024 |
8-K announcing full over-allotment exercise
Sign In to view filing content. |
| Apr 10, 2024 |
8-K announcing separate trading of shares and rights
Sign In to view filing content. |
| Sep 3, 2024 |
8-K announcing non-binding LOI with Shanghai Maius Pharmaceutical Technology Co.
Sign In to view filing content. |
| Oct 23, 2024 |
8-K announcing business combination with Maius Pharmaceutical
Sign In to view filing content. |